Baillie Gifford & CO Trans Medics Group, Inc. Transaction History

Baillie Gifford & CO

$128 Billion
Q2 2025

A detailed history of Baillie Gifford & CO transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 262,961 shares of TMDX stock, worth $31.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

262,961

Previous 259,677 1.26%

Holding current value

$31.5 Million

Previous $17.5 Million 101.7%

% of portfolio

0.03%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	BUY	$67.67 - $143.04 $222,228 - $469,743	3,284 Added 1.26%	262,961 $35.2 Million
Q1 2025 May 07, 2025	SELL	$56.73 - $79.42 $576,320 - $806,827	-10,159 Reduced 3.76%	259,677 $17.5 Million
Q4 2024 Jan 31, 2025	BUY	$59.28 - $144.9 $2.07 Million - $5.06 Million	34,947 Added 14.88%	269,836 $16.8 Million
Q3 2024 Nov 05, 2024	SELL	$135.68 - $176.11 $3.06 Million - $3.98 Million	-22,577 Reduced 8.77%	234,889 $36.9 Million
Q2 2024 Jul 25, 2024	SELL	$72.62 - $150.62 $3.32 Million - $6.88 Million	-45,696 Reduced 15.07%	257,466 $38.8 Million
Q1 2024 May 01, 2024	SELL	$70.86 - $89.93 $412,121 - $523,032	-5,816 Reduced 1.88%	303,162 $22.4 Million
Q4 2023 Jan 26, 2024	SELL	$36.74 - $81.08 $1.07 Million - $2.37 Million	-29,184 Reduced 8.63%	308,978 $24.4 Million
Q3 2023 Nov 13, 2023	BUY	$53.47 - $96.07 $5.17 Million - $9.28 Million	96,609 Added 39.99%	338,162 $18.5 Million
Q2 2023 Jul 28, 2023	SELL	$66.23 - $88.73 $756,280 - $1.01 Million	-11,419 Reduced 4.51%	241,553 $20.3 Million
Q1 2023 May 03, 2023	SELL	$53.63 - $82.33 $18,609 - $28,568	-347 Reduced 0.14%	252,972 $19.2 Million
Q4 2022 Jan 24, 2023	BUY	$39.08 - $64.29 $8.52 Million - $14 Million	218,048 Added 618.21%	253,319 $15.6 Million
Q3 2022 Oct 27, 2022	BUY	$31.56 - $55.75 $48,728 - $86,078	1,544 Added 4.58%	35,271 $1.47 Million
Q2 2022 Aug 08, 2022	SELL	$20.56 - $32.15 $29,853 - $46,681	-1,452 Reduced 4.13%	33,727 $1.06 Million
Q1 2022 May 05, 2022	BUY	$12.58 - $26.94 $78,096 - $167,243	6,208 Added 21.43%	35,179 $948,000
Q4 2021 Jan 20, 2022	BUY	$19.16 - $32.68 $531,670 - $906,837	27,749 Added 2270.79%	28,971 $555,000
Q3 2021 Oct 19, 2021	BUY	$25.92 - $34.51 $21,306 - $28,367	822 Added 205.5%	1,222 $40,000
Q1 2021 May 06, 2021	BUY	$17.75 - $47.82 $7,100 - $19,128	400 New	400 $17,000

Others Institutions Holding TMDX

# of Institutions

421

Shares Held

30M

Call Options Held

1.19M

Put Options Held

777K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $3.82B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Trans Medics Group, Inc. Transaction History